E

Epicbio

greenhouse
4 open positions
Last updated May 5, 2026

Scientist I/ Scientist II, Bioanalytical

$165k–$184k/year
39
Lowest

Who Are We? Our company is based on the science of our founder, Stanley Qi, one of the original CRISPR co-inventors who then furthered the technology so that DNA does not need to be cut to accomplish gene regulation. Instead, we regulate the epigenome to suppress and activate multiple genes simultan

OtherPrincipalScientistLead
See 3 similar>
Quick Apply
2 0 0 ~14d ago

Research Associate II/Senior Research Associate, Process Development

$90k–$108k/year
39
Lowest

Who Are We? Our company is based on the science of our founder, Stanley Qi, one of the original CRISPR co-inventors who then furthered the technology so that DNA does not need to be cut to accomplish gene regulation. Instead, we regulate the epigenome to suppress and activate multiple genes simultan

OtherResearch AssociateDevelopmentLaboratory & Life SciencesSenior
See 4 similar>
Quick Apply
1 0 0 19d ago

Executive Assistant / Office Manager

$120k–$165k/year
34
Lowest

Who Are We? Our company is based on the science of our founder, Stanley Qi, one of the original CRISPR co-inventors who then furthered the technology so that DNA does not need to be cut to accomplish gene regulation. Instead, we regulate the epigenome to suppress and activate multiple genes simultan

OtherExecutive AssistantAdministrative & OfficeAssistant Office ManagerAdministration & Office SupportMid
See 5 similar>
Quick Apply
7 0 0 1mo ago

Scientist II/Senior Scientist Nonclinical Development

$130k–$160k/year
34
Lowest

Who Are We? Our company is based on the science of our founder, Stanley Qi, one of the original CRISPR co-inventors who then furthered the technology so that DNA does not need to be cut to accomplish gene regulation. Instead, we regulate the epigenome to suppress and activate multiple genes simultan

OtherHealthcareDevelopmentSenior
See 3 similar>
Quick Apply
6 0 0 3mo ago

Insights will appear once this company has published more listings.